Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Fatemi, S Hossein
Emamian, Effat-S
and
Kist, David A
1999.
Venlafaxine and Bupropion Combination Therapy in a Case of Treatment-Resistant Depression.
Annals of Pharmacotherapy,
Vol. 33,
Issue. 6,
p.
701.
Soyka, M.
2004.
Neuropsychiatric adverse events of bupropion treatment: a brief update.
International Journal of Psychiatry in Clinical Practice,
Vol. 8,
Issue. 4,
p.
251.
Cheng, Wan-Chen
Liu, Chih-Min
Hsieh, Ming H.
and
Hwang, Tzung-Jeng
2009.
Bupropion-Related Parkinsonism and Dystonia.
Journal of Clinical Psychopharmacology,
Vol. 29,
Issue. 6,
p.
616.
Javelot, Hervé
Baratta, Alexandre
Weiner, Luisa
Javelot, Thierry
Nonnenmacher, Cathy
Westphal, Jean-Frédéric
and
Messaoudi, Michaël
2009.
Two acute psychotic episodes after administration of bupropion: a case of involuntary rechallenge.
Pharmacy World & Science,
Vol. 31,
Issue. 2,
p.
238.
Kumar, Sanjeev
Kodela, Sreekant
Detweiler, Jonna G.
Kim, Kye Y.
and
Detweiler, Mark B.
2011.
Bupropion-induced psychosis: folklore or a fact? A systematic review of the literature.
General Hospital Psychiatry,
Vol. 33,
Issue. 6,
p.
612.
Englisch, Susanne
Morgen, Katrin
Meyer-Lindenberg, Andreas
and
Zink, Mathias
2013.
Risks and Benefits of Bupropion Treatment in Schizophrenia.
Clinical Neuropharmacology,
Vol. 36,
Issue. 6,
p.
203.
eLetters
No eLetters have been published for this article.